Braeden Lichti - 21 Dec 2023 Form 4 Insider Report for MARIZYME, INC. (MRZM)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
28 Dec 2023, 20:06:45 UTC
Prior SEC filing
08 Sep 2023
Next SEC filing
01 Feb 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Braeden Lichti

Key filing fact

Braeden Lichti filed Form 4 for MARIZYME, INC. (MRZM) on 28 Dec 2023.

Key facts

  • This page summarizes Braeden Lichti's Form 4 filing for MARIZYME, INC. (MRZM).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 28 Dec 2023, 20:06.

Change

  • Previous filing in this sequence was filed on 08 Sep 2023.
  • Current net transaction value: -$381,529.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MRZM transaction

Common stock

Conversion of derivative security

Transaction value
$381,529
Shares
-3,815,294
Change %
-22%
Price
$0.1000
Shares after
13,293,841
Date
21 Dec 2023
Ownership
BWL Investments Ltd
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MRZM transaction Derivative

10% Secured Convertible Promissory Note

Conversion of derivative security

Transaction value
$0
Shares
-2
Change %
Price
$0.000000
Shares after
$0
Date
21 Dec 2023
Ownership
BWL Investments Ltd
Underlying class
Common Stock
Underlying amount
$381,529
Exercise price
$0.1000
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents conversion of the principal amount of, and accrued interest on, 10% Secured Convertible Promissory Notes into shares of Common Stock of the Issuer at a conversion price of $0.1 per share.

Footnote F2

Owned by BWL Investments Ltd, LLC, a company owned and controlled by Braeden Lichti.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .